Ph.D., Charles E. and Susan T. Harris Professor, MIT
Biography
Dr. Los healthcare-related research interests include: new financial engineering tools and business models for drug and device development and healthcare delivery; statistical methods for incorporating patient preferences into the drug approval process; predicting clinical trial outcomes via machine learning techniques; and novel funding and reimbursement models for creating a robust gene therapy ecosystem. He is a co-founder and director of BridgeBio Pharma, a director of AbCellera, Atomwise, and Roivant Sciences, a co-founder and chairman of QLS Advisors, and a member of the advisory boards of NCATS and the American Cancer Society’s BrightEdge Impact Fund.
Session Abstract – PMWC 2023 Silicon Valley
Track 1 - January 25 9.00 A.M.-4.15 P.M.
Track Co-Chairs:
Yael Weiss, Mahzi
Peter Marks, FDA
- Welcome and Opening by Track Chairs: Yael Weiss, Mahzi
- PMWC 2023 Luminary Award Ceremony
- Allyson Berent, Angelman Foundation
- Terry Pirovolakis, CureSPG50 - From Bench to Bedside - Biomarkers, Natural History Studies, Animal Models (PANEL)
Chair: Peter Marks, FDA (Allyson Berent, FAST)
- Emil Kakkis, Ultragenyx
- Alysson Muotri, UCSD
- Nasha Fitter, Invitae - Commercialization - Moving from Rare to Common (PANEL)
Chair: Matthew Patterson, Vor Bio
- Shankar Ramaswamy, Kriya
- Rahul Singhvi, Resilience
- Sarah Glass, Ultragenyx
- Andrew Lo, MIT
- Mark Harrison, University of British Colombia - Future Modalities (PANEL)
Chair: Shannon Muir, CIAPM
- Nadav Ahituv, UCSF
- Amber Salzman, Epic Bio
- Ben Oakes, Scribe Therapeutics - PMWC NCI Showcase
- Michael M. Binkley, OpenCell
- Cellular Rejuvenation Programming
- Hana El-Samad, UCSF - Bioethics & Ethical Implications in Cell and Gene Therapies
- Hank Greely, Stanford
- Patient Driven Therapies: The Challenges and Successes (PANEL)
Chair: Yael Weiss, Mahzi
- Terry Pirovolakis, CureSPG50
- Allyson Berent, Angelman Foundation
- PMWC Showcase - Peter Marinkovich, Stanford
